Conference
A phase II study of temsirolimus (CCI-779) in patients with metastatic and/or locally advanced recurrent endometrial cancer previously treated with chemotherapy: NCIC CTG IND 160b
Authors
Oza AM; Elit L; Provencher D; Biagi JJ; Panasci L; Sederias J; Dancey JE; Tsao MS; Eisenhauer EA
Volume
26
Pagination
pp. 5516-5516
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
May 20, 2008
DOI
10.1200/jco.2008.26.15_suppl.5516
Conference proceedings
Journal of Clinical Oncology
Issue
15_suppl
ISSN
0732-183X